Assura PLC
LSE:AGR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its 3-Year Average (26), the stock would be worth GBX45.9 (3% downside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 26.9 | GBX47.48 |
0%
|
| 3-Year Average | 26 | GBX45.9 |
-3%
|
| 5-Year Average | 26.9 | GBX47.48 |
0%
|
| Industry Average | 0.1 | GBX0.18 |
-100%
|
| Country Average | 0 | GBX0.07 |
-100%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Assura PLC
LSE:AGR
|
1.5B GBP | 26.9 | 9.3 | |
| US |
|
Welltower Inc
NYSE:WELL
|
153.2B USD | 119.4 | 108.8 | |
| US |
|
Ventas Inc
NYSE:VTR
|
41.7B USD | 52.2 | 166 | |
| US |
|
Omega Healthcare Investors Inc
NYSE:OHI
|
13.9B USD | 111.6 | 24.2 | |
| US |
H
|
Healthpeak Properties Inc
F:HC5
|
9.5B EUR | -151.8 | 157 | |
| US |
|
Physicians Realty Trust
NYSE:DOC
|
11.2B USD | -153.5 | 159.8 | |
| US |
C
|
CareTrust REIT Inc
NYSE:CTRE
|
8.8B USD | -9.9 | 27.5 | |
| BE |
|
Aedifica NV
XBRU:AED
|
6B EUR | 35.9 | 24.5 | |
| US |
|
Healthcare Realty Trust Inc
NYSE:HR
|
6.6B USD | 92.2 | -26.5 | |
| US |
H
|
Healthcare Trust Of America Inc
F:HT01
|
5.3B EUR | -252.8 | 66.4 | |
| US |
|
Sabra Health Care REIT Inc
NASDAQ:SBRA
|
5.2B USD | -73.9 | 33.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0.1 |
| Max | 1 344.9 |
Other Multiples
Assura PLC
Glance View
In the ever-evolving landscape of healthcare infrastructure, Assura PLC has carved out a niche, specializing in the development and management of primary care properties across the UK. With a keen understanding of the public and private sector disparities within the healthcare industry, Assura operates essentially as a real estate investment trust (REIT), focusing on assets that provide essential healthcare services. Their business model is grounded in creating and maintaining robust and modern facilities that serve as the backbone for general practitioners, dentists, and other community health services. By partnering with the National Health Service (NHS), Assura ensures that these facilities not only meet current standards but also anticipate future healthcare needs, ensuring long-term sustainability and growth opportunities. Revenue generation for Assura PLC primarily revolves around rental income derived from the leasing of these healthcare properties. With a portfolio spanning several hundred properties, Assura capitalizes on long-term leases, often with inflation-linked rent reviews, providing them with a stable and predictable income. This strategy affords them the advantage of minimizing vacancy risks, given their collaboration with the NHS and the ongoing demand for modern healthcare facilities. By focusing on niche real estate like medical centers and community hospitals, Assura aligns its financial objectives with the critical needs of public health infrastructure, positioning itself as an essential player in ensuring the organic expansion of primary healthcare services throughout the UK.